Yasunori Kaneko
Director/Board Member bei ARCUS BIOSCIENCES, INC.
Vermögen: 17 Mio $ am 31.03.2024
Profil
Yasunori Kaneko is currently the Lead Independent Director at Arcus Biosciences, Inc. and a Director at Provigate KK.
He previously held positions as a Director at LeukoSite, Inc., KAI Pharmaceuticals, Inc., Guava Technologies, Inc., and H.U.
Group Holdings, Inc. He was also an Independent Outside Director at Nippon Paint Holdings Co., Ltd.
from 2018 to 2020.
From 1999 to 2019, he was the Managing Director at Skyline Management LLC.
He also held positions as the Chief Financial Officer & Senior Vice President at Ionis Pharmaceuticals, Inc. from 1991 to 1992 and as the Chief Financial Officer & VP-Business Development at Tularik, Inc. from 1992 to 1998.
Prior to that, he was the Head-Corporate Finance at Paribas Capital Markets from 1987 to 1991.
Dr. Kaneko received his undergraduate and doctorate degrees from Keio University and his MBA from Stanford Graduate School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARCUS BIOSCIENCES, INC.
0,99% | 01.03.2024 | 903 755 ( 0,99% ) | 17 Mio $ | 31.03.2024 |
Aktive Positionen von Yasunori Kaneko
| Unternehmen | Position | Beginn |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Director/Board Member | 01.05.2015 |
Provigate KK
 Provigate KK Medical SpecialtiesHealth Technology Provigate KK engages in the development, manufacture and sale of blood glucose level measuring instrument. The company was founded in March 2015 and is headquartered in Tokyo, Japan. | Director/Board Member | - |
Ehemalige bekannte Positionen von Yasunori Kaneko
| Unternehmen | Position | Ende |
|---|---|---|
| NIPPON PAINT HOLDINGS CO., LTD. | Director/Board Member | 01.03.2020 |
Skyline Management LLC
 Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 01.01.2019 |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Director/Board Member | 01.01.1999 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Director of Finance/CFO | 01.01.1998 |
| IONIS PHARMACEUTICALS, INC. | Director of Finance/CFO | 01.01.1992 |
Ausbildung von Yasunori Kaneko
| Keio University | Doctorate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| NIPPON PAINT HOLDINGS CO., LTD. | Process Industries |
| H.U. GROUP HOLDINGS, INC. | Health Services |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Skyline Management LLC
Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California. | Finance |
Guava Technologies, Inc.
 Guava Technologies, Inc. BiotechnologyHealth Technology Guava Technologies, Inc. develops, manufactures and commercializes cytometry systems for cellular analyses. Its products include Guava Personal Cell Analysis systems, Guava PCA, Guava PCA-96, and Guava EasyCyte systems. The company was founded by Goix J. Philippe in 1998 and is headquartered in Hayward, CA. | Health Technology |
| Paribas Capital Markets | Finance |
Provigate KK
Provigate KK Medical SpecialtiesHealth Technology Provigate KK engages in the development, manufacture and sale of blood glucose level measuring instrument. The company was founded in March 2015 and is headquartered in Tokyo, Japan. | Health Technology |
